The ABL p24 ELISA kit, originally developed for HIV titer determination, has evolved into a critical tool for the quantification of lentiviral vector (LVV) titers in cell and gene therapy applications. This study highlights its performance in detecting LVV titers across in-process samples during industrial-scale lentiviral production and purification. Comparative analysis with four other commercial Read More The post Performance Evaluation of the ABL p24 ELISA Kit for Accurate Lentiviral Vector Titer Determination in Cell and Gene Therapy Applications appeared first on Ascend .